[Clinical course of a solitary retinal astrocytoma].

Ophthalmologe

Augenklinik, Universitätsspital Zürich, Frauenklinikstrasse 24, 8091 Zürich, Schweiz.

Published: October 2009

Retinal astrocytomas are benign tumors of the retina. Their localization can be solitary, multiple, or bilateral in both eyes. It is also known that they can be part of a phakomatosis syndrome (i.e., tuberous sclerosis or neurofibromatosis). Because retinal astrocytomas have a slow growth rate, yearly controls by an ophthalmologist with interdisciplinary consultation are adequate. Some uncommon cases have been reported in which the tumor has grown more aggressively. These tumors may require therapeutic interventions (e.g., vitreoretinal surgery, brachytherapy, photodynamic therapy, or cryotherapy).

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00347-009-1927-zDOI Listing

Publication Analysis

Top Keywords

retinal astrocytomas
8
[clinical course
4
course solitary
4
solitary retinal
4
retinal astrocytoma]
4
astrocytoma] retinal
4
astrocytomas benign
4
benign tumors
4
tumors retina
4
retina localization
4

Similar Publications

Glioblastoma (GB) is an aggressive malignant central nervous system tumor that is currently incurable. One of the main pitfalls of GB treatment is resistance to the chemotherapeutic standard of care, temozolomide (TMZ). The role of aldehyde dehydrogenases (ALDHs) in the glioma stem cell (GSC) subpopulation has been related to chemoresistance.

View Article and Find Full Text PDF

Purpose: To determine whether microstructural retinal changes, tumor features, and polymorphism are correlated with clinically detectable treatment-associated cognitive dysfunction (TACD) in patients with lower-grade gliomas.

Design: Cohort study.

Participants And Controls: Sixteen patients with lower-grade glioma at a United States academic ophthalmology department between January 2021 and November 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!